Bionano Genomics Stocks (BNGO, $0.81): Big Opportunities for Robots on Strong Volatility +14%
Bionano Genomics stocks rose by over 14% ($0.81) yesterday, and our robots were quick to spot this opportunity, generating more than a 10% profit on this stock in just one day. We'd like to highlight our Swing Trader Volatility Balanced Strategy v2 TA robot, which is gaining momentum once again.
Introducing our AI robot - the perfect solution for traders seeking a balanced strategy. This advanced technology opens no more than 30 trades at a time, with an average duration of 2 days. We have carefully selected a set of stocks with high and medium volatility, giving traders the flexibility to adjust the algorithms for opening trades based on market activity.
Here's how our AI robot works: it first evaluates short- and medium-term trends for each stock using complex algorithms. Then, using a proprietary set of technical indicators, it looks for a signal to open a trade. Finally, based on the volatility and direction of both types of trends, a separate algorithm determines the position size to be opened.
Once a trade is entered, our AI robot places an order for "Take Profit," with the distance depending on the current market volatility. It uses a stop loss of 3% of the position opening price and a flexible trailing stop to exit positions, enabling traders to save most of the profit if the market reverses.
The robot's trading results are displayed without using margin. To view the full trading statistics and equity chart, click on the "Show More" button on the robot page. Traders can watch live as our AI robot selects equities, enters and exits paper trades on the "Open Trades" tab, while the "Closed Trades" tab provides a complete record of all previous trades made by our AI robot.
To maximize profits, we recommend subscribing to several robots at once. Good luck with your trading!
BNGO's RSI Indicator is sitting in oversold zone for 8 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on January 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BNGO as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BNGO turned negative on January 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at .
BNGO moved below its 50-day moving average on January 08, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BNGO crossed bearishly below the 50-day moving average on January 16, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNGO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BNGO broke above its upper Bollinger Band on January 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BNGO entered a downward trend on February 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.597) is normal, around the industry mean (23.476). P/E Ratio (0.000) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.993) is also within normal values, averaging (41.270).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BNGO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a developer of technologies for analysis of large biological molecules
Industry MedicalSpecialties